Tides®, Boston, MA, USA
Event May 01
•Big Pharma's Perspective on the Future of Oligo-Based Therapeutics.
•Novel Technologies and Commercialization Strategies for Therapeutics, Diagnostics, and Research.
•Supply Chain: Minimizing Risk and Improving Economics
•Updates on Leading Clinical and Preclinical Candidates from Eyetech, Cubist, Human Genome Sciences, Coley Pharmaceuticals and Corgentech - and more